Phase II study of neoadjuvant Letrozole combined with low dose metronomic Cyclophosphamide for postmenopausal women with Endocrine-responsive Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2015
At a glance
- Drugs Cyclophosphamide (Primary) ; Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 24 Aug 2015 Status changed from active,no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 25 Aug 2008 New trial record.